Home  |  Contact

UniProtKB/Swiss-Prot O94925: Variant p.Ser482Cys

Glutaminase kidney isoform, mitochondrial
Gene: GLS
Variant information

Variant position:  482
The position of the amino-acid change on the UniProtKB canonical protein sequence.

Type of variant:  LP/P [Disclaimer]
The variants are classified into three categories: LP/P, LB/B and US.
  • LP/P: likely pathogenic or pathogenic.
  • LB/B: likely benign or benign.
  • US: uncertain significance

Residue change:  From Serine (S) to Cysteine (C) at position 482 (S482C, p.Ser482Cys).
Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.

Physico-chemical properties:  Change from small size and polar (S) to medium size and polar (C)
The physico-chemical property of the reference and variant residues and the change implicated.

BLOSUM score:  -1
The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another:
  • Lowest score: -4 (low probability of substitution).
  • Highest score: 11 (high probability of substitution).
More information can be found on the following page

Variant description:  In CASGID; increased enzyme activity.
Any additional useful information about the variant.

Other resources:  
Links to websites of interest for the variant.



Sequence information

Variant position:  482
The position of the amino-acid change on the UniProtKB canonical protein sequence.

Protein sequence length:  669
The length of the canonical sequence.

Location on the sequence:   SCGMYDFSGQFAFHVGLPAK  S GVAGGILLVVPNVMGMMCWS
The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.

Residue conservation: 
The multiple alignment of the region surrounding the variant against various orthologous sequences.

Human                         SCGMYDFSGQFAFHVGLPAKSGVAGGILLVVPNVMGMMCWS

Mouse                         SCGMYDFSGQFAFHVGLPAKSGVAGGILLVVPNVMGMMCWS

Rat                           SCGMYDFSGQFAFHVGLPAKSGVAGGILLVVPNVMGMMCWS

Sequence annotation in neighborhood:  
The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:
  • Type: the type of sequence feature.
  • Positions: endpoints of the sequence feature.
  • Description: contains additional information about the feature.

TypePositionsDescription
Chain 55 – 669 Glutaminase kidney isoform, mitochondrial 68 kDa chain
Chain 73 – 669 Glutaminase kidney isoform, mitochondrial 65 kDa chain
Binding site 466 – 466 Substrate
Binding site 484 – 484 Substrate; via amide nitrogen
Alternative sequence 170 – 669 Missing. In isoform 2.
Mutagenesis 466 – 466 Y -> A. Loss of enzyme activity.
Beta strand 480 – 482


Literature citations

GLS hyperactivity causes glutamate excess, infantile cataract and profound developmental delay.
Rumping L.; Tessadori F.; Pouwels P.J.W.; Vringer E.; Wijnen J.P.; Bhogal A.A.; Savelberg S.M.C.; Duran K.J.; Bakkers M.J.G.; Ramos R.J.J.; Schellekens P.A.W.; Kroes H.Y.; Klomp D.W.J.; Black G.C.M.; Taylor R.L.; Bakkers J.P.W.; Prinsen H.C.M.T.; van der Knaap M.S.; Dansen T.B.; Rehmann H.; Zwartkruis F.J.T.; Houwen R.H.J.; van Haaften G.; Verhoeven-Duif N.M.; Jans J.J.M.; van Hasselt P.M.;
Hum. Mol. Genet. 28:96-104(2019)
Cited for: FUNCTION; INVOLVEMENT IN CASGID; VARIANT CASGID CYS-482; CHARACTERIZATION OF VARIANT CASGID CYS-482;

Disclaimer: Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.